Company Overview
Snapshot
Founded in March 2020 by Amnon Bar-Lev, Ohad Zadok, and Varda Shalev, Alike operates with 11–50 employees. The company has raised $5 million across two funding rounds from two investors. In May 2020, Pitango HealthTech led a Seed round.
Business overview
Alike is a digital healthcare company that leverages proprietary AI, crowdsourcing, and big data to deliver personalized health insights. Its transformative platform connects individuals based on critical factors such as age, gender, comorbidities, medications, and diet, fostering a community for knowledge sharing and support. The company utilizes machine learning to group users with similar medical profiles, generating precise personalized insights and connecting them to communities of "Alikes" facing similar challenges. Alike operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Therapeutics, serving patients.
Strategic signal
In October 2021, Alike.Health was selected for Google's inaugural European acceleration program for medical startups. This signals external validation of Alike's AI-based self-monitoring system and its potential to innovate within the digital health landscape, attracting strategic partnerships and further development opportunities.
Company Intelligence Q&A
- What is Alike's primary focus?
- Alike focuses on personalized health by utilizing AI, crowdsourcing, and big data to analyze medical records and connect patients with similar profiles for shared insights and support.
- When was Alike founded and by whom?
- Alike was founded in March 2020 by Amnon Bar-Lev, Ohad Zadok, and Varda Shalev.
- What was a significant early funding event for Alike?
- In May 2020, Alike secured a $5 million Seed funding round led by Pitango HealthTech.
- What recognition did Alike receive from Google?
- In October 2021, Alike.Health was selected for Google's first European acceleration program dedicated to medical startups.
- What is the current operational status of Alike?
- Alike is currently non-active, having ceased operations in November 2024.